— Know what they know.
Not Investment Advice
Also trades as: MIR-WT (NYSE)

MIR NYSE

Mirion Technologies, Inc.
1W: +6.9% 1M: -8.7% 3M: -14.5% YTD: -29.2% 1Y: -22.5% 3Y: +112.9% 5Y: +63.4%
$16.79
-0.06 (-0.36%)
 
Weekly Expected Move ±5.9%
$15 $16 $17 $18 $19
NYSE · Industrials · Industrial - Machinery · Alpha Radar Neutral · Power 47 · $4.1B mcap · 225M float · 1.80% daily turnover · Short 57% of daily vol
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$4.1B
52W Range15.57-30.277
Volume2,902,719
Avg Volume4,063,159
Beta1.03
Dividend
Analyst Ratings
8 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOThomas D. Logan
Employees3,281
SectorIndustrials
IndustryIndustrial - Machinery
IPO Date2020-08-20
Websitemirion.com
1218 Menlo Drive
Atlanta, GA 30318
US
770 432 2744
About Mirion Technologies, Inc.

Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).

Recent Insider Trades

NameTypeSharesPriceDate
Kingsley Lawrence D A-Award 1,095 $17.46 2026-06-30
Kingsley Lawrence D A-Award 7,383 2026-05-13
Bockhorst Kenneth A-Award 7,383 2026-05-13
CASCELLA ROBERT A-Award 7,383 2026-05-13
Etzel Steven W. A-Award 7,383 2026-05-13

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms